Latest news from Cochrane
Why evidence synthesis matters in the age of AI
22 July 2026
In an era defined by an abundance of information, and new ways to find it, Cochrane’s Chief Executive Officer, Karla Soares-Weiser argues that systematic reviews remain an essential tool to help individuals, healthcare professionals and policymakers make decisions. However, the challenge is no longer simply producing reliable evidence but maintaining the trust that makes Cochrane’s evidence useful.
Building a volunteer network through Cochrane Engage
16 July 2026
Knowledge translation (KT) is a key part of ensuring that high-quality evidence reaches the people who can use it. In Italy, however, research methods and evidence-based medicine (EBM) are not consistently integrated into higher education or medical education programmes.
World Evidence-based Healthcare Day launches its 2026 campaign
24 June 2026
Today an international coalition of organizations dedicated to evidence-informed decision-making launched the World Evidence-based Healthcare Day 2026 campaign, ‘Evidence and AI: People at the Centre’.
Cochrane at the 79th World Health Assembly
16 June 2026
Following a busy week at the 79th World Health Assembly (WHA), we’re reflecting on the inspiring conversations and high-level discussions Cochrane had the privilege of being involved in.
Breast cancer risk models fall short for women with family history
1 June 2026
Researchers from Trinity College Dublin, St James’s Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.
Early birth safer for mother and baby in high blood pressure pregnancies
21 May 2026
Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.
Screening modestly reduces prostate cancer deaths
11 May 2026
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.
Anti-amyloid Alzheimer’s drugs show no clinically meaningful effect
16 April 2026
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.
Simple antiseptic can reduce newborn infections
26 March 2026
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.
Our newsletters
Get regular news about different areas of our work in your inbox. Sign up for a Cochrane account and opt into newsletters in the 'Communications' tab to subscribe.
- Patient and Public Network newsletter: monthly digest for patients and members of the public about health evidence, and helping to create it
- Early Career Professionals Network newsletter: regular resources, training, events, opportunities, features and blogs relevant to Early Career Researchers
- Author Digest: monthly updates and tips on writing systematic reviews
- Cochrane Evidence Synthesis and Methods journal: sign up for alerts on our publisher's website
- Cochrane Library newsletter: updates on new Cochrane Library features, enhancements and the latest evidence. Sign up on our publisher's website.
Media enquiries
Please see our Press office page.
